NAYZILAM® (midazolam) Results Published in Epilepsy & Behavior Examining the Impact of Dose on Return to Full Baseline Function (RTFBF) for People with Seizure Clusters
Categories News Press Releases Archives 2026 June May April March February 2025 December November October September August July June May April March February January 2024 December November October September August July June May April March February January 2023 December November October September August July June April March February January 2022 December November September August June May March February January 2021 December November October September August May April February Nov 22 UCB Submits Response to FDA Complete Response Letter for Bimekizumab Read More Nov 14 UCB announces U.S. FDA acceptance of new drug application and EMA MAA validation for zilucoplan for the treatment of generalized myasthenia gravis in adult patients Read More
